Intellia Therapeutics, Inc.·3

Mar 23, 5:29 PM ET

Novartis Institutes for BioMedical Research, Inc. 3

3 · Intellia Therapeutics, Inc. · Filed Mar 23, 2018

Insider Transaction Report

Form 3
Period: 2018-03-16
Holdings
  • Common Stock

    4,277,073
Footnotes (1)
  • [F1]The shares are held directly by Novartis Institutes for BioMedical Research, Inc. ("NIBRI"). NIBRI is an indirect wholly-owned subsidiary of Novartis AG.

Documents

1 file
  • 3
    a3.xmlPrimary

    3